A Breath of Fresh Air: Grade 4 Pneumonitis Secondary to HER2 Antibody-Drug Conjugate Therapy Treated with Plasma Exchange

被引：0
|
作者：
Teng, Christina [1 ,2 ]
Wei, Joe Q. [1 ,2 ,3 ]
Killen, Andrew [1 ]
Thirumaran, Aricia [2 ]
Lemech, Charlotte R. [1 ,2 ,4 ]
机构：
[1] Scientia Clin Res, Randwick, NSW, Australia
[2] Prince Wales Hosp, Randwick, NSW, Australia
[3] Univ Sydney, Camperdown, NSW, Australia
[4] Univ New South Wales, Kensington, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] Evaluation of HER2 expression in low grade serous carcinoma of the ovary in the antibody-drug conjugate era
    Cockenpot, Vincent
    Alam, Elsy El
    Weber, Nina
    Becette, Veronique
    Rodrigues, Manuel
    Vincent-Salomon, Anne
    Lecuru, Fabrice
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A413 - A413
  • [2] Reversible HER2 antibody-drug conjugate-induced ocular toxicity
    Kryshtalskyj, Michael
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (02): : E35 - E36
  • [3] Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
    Lei, Huizi
    Ling, Yun
    Yuan, Pei
    Yan, Xieqiao
    Wang, Lin
    Shi, Yanxia
    Yao, Xin
    Luo, Hong
    Shi, Benkang
    Liu, Jiyan
    He, Zhisong
    Yu, Guohua
    Han, Weiqing
    Hu, Changlu
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Fang, Jianmin
    Guo, Jun
    Sheng, Xinan
    Zhou, Aiping
    Ying, Jianming
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (02): : 121 - 128
  • [4] HER2 antibody-cytotoxic drug conjugate is the promising targeted therapy for HER2 overexpressing bladder cancer
    Ohara, Shinya
    Hayashi, Tetsutaro
    Sekino, Yohei
    Goto, Keisuke
    Shinmei, Shunsuke
    Teishima, Jun
    Matsubara, Akio
    Sentani, Kazuhiro
    Oue, Naohide
    Yasui, Wataru
    CANCER SCIENCE, 2021, 112 : 839 - 839
  • [5] Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63
    de Goeij, Bart E. C. G.
    Vink, Tom
    ten Napel, Hendrik
    Breij, Esther C. W.
    Satijn, David
    Wubbolts, Richard
    Miao, David
    Parren, Paul W. H. I.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2688 - 2697
  • [6] The Latest Research and Development into the Antibody-Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
    Nakada, Takashi
    Sugihara, Kiyoshi
    Jikoh, Takahiro
    Abe, Yuki
    Agatsuma, Toshinori
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 67 (03) : 173 - 185
  • [7] Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Liu, Bo
    Drago, Joshua Z.
    Rao, Yi
    Pereira, Patricia R.
    Safonov, Anton
    Marra, Antonio
    Ahmed, Mehnaj S.
    Modi, Shanu
    Reis-Filho, Jorge S.
    Montemurro, Filippo
    Razavi, Pedram
    Lewis, Jason S.
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
    Hongfu Liu
    Dongdong Zhou
    Dongqin Liu
    Xi Xu
    Kai Zhang
    Ruxia Hu
    Peng Xiong
    Changxin Wang
    Xiangfu Zeng
    Liefeng Wang
    Shuyong Zhang
    Cell Death & Disease, 15
  • [9] Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
    Liu, Hongfu
    Zhou, Dongdong
    Liu, Dongqin
    Xu, Xi
    Zhang, Kai
    Hu, Ruxia
    Xiong, Peng
    Wang, Changxin
    Zeng, Xiangfu
    Wang, Liefeng
    Zhang, Shuyong
    CELL DEATH & DISEASE, 2024, 15 (03)
  • [10] Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy
    Jia, Jia
    Mao, Lili
    Lin, Jing
    Li, Wenyu
    Yuan, Pei
    Guo, Lei
    Dai, Jie
    Li, Caili
    Bai, Xue
    Li, Zhongwu
    Chen, Yu
    Guo, Jun
    Ying, Jianming
    Si, Lu
    FRONTIERS OF MEDICINE, 2024, 18 (03) : 565 - 569
12345